logo-loader
ASX:NOX OTC:NOXOF

Noxopharm Ltd

Receive alerts
Market:
ASX
Price
0.07 AUD
Day Change
3.08%
Market Cap:
$19.58 m
52 weeks high
0.17
52 weeks low
0.03

In brief

Noxopharm Ltd (ASX:NOX) is an innovative Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance mRNA vaccines. 

The company has three active drug development programs: its clinical drug candidate Veyonda®, plus two innovative technology platforms – ChromaTM (oncology) and SofraTM (mRNA vaccines, inflammation and autoimmunity), which provide the basis for active development of a growing pipeline of new proprietary drugs.

Snapshot

  • Noxopharm extends strategic partnership with Hudson Institute of Medical Research
  • Noxopharm talks partnership with Hudson Institute of Medical Research